Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Palivizumab in the prevention of respiratory syncytial virus disease.

Krilov LR.

Expert Opin Biol Ther. 2002 Oct;2(7):763-9. Review.

PMID:
12387675
2.

Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus.

Peacock SJ, Moore CE, Justice A, Kantzanou M, Story L, Mackie K, O'Neill G, Day NP.

Infect Immun. 2002 Sep;70(9):4987-96.

3.

Staphylococcus aureus resistant to vancomycin--United States, 2002.

Centers for Disease Control and Prevention (CDC)..

MMWR Morb Mortal Wkly Rep. 2002 Jul 5;51(26):565-7.

4.

Novel agents for resistant Gram-positive infections--a review.

Strahilevitz J, Rubinstein E.

Int J Infect Dis. 2002 Mar;6 Suppl 1:S38-46. Review.

PMID:
12044288
5.

Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation.

Snydman DR.

Transpl Infect Dis. 2001;3 Suppl 2:6-13. Review.

PMID:
11926753
6.
7.

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

Shinefield H, Black S, Fattom A, Horwith G, Rasgon S, Ordonez J, Yeoh H, Law D, Robbins JB, Schneerson R, Muenz L, Fuller S, Johnson J, Fireman B, Alcorn H, Naso R.

N Engl J Med. 2002 Feb 14;346(7):491-6.

8.

Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.

Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T.

J Infect Dis. 2001 Dec 15;184(12):1572-80. Epub 2001 Dec 3.

PMID:
11740733
9.
10.

Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat.

Rennermalm A, Li YH, Bohaufs L, Jarstrand C, Brauner A, Brennan FR, Flock JI.

Vaccine. 2001 May 14;19(25-26):3376-83.

PMID:
11348701
11.
12.

Clumping factor A mediates binding of Staphylococcus aureus to human platelets.

Siboo IR, Cheung AL, Bayer AS, Sullam PM.

Infect Immun. 2001 May;69(5):3120-7.

13.

Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii.

Stutzmann Meier P, Entenza JM, Vaudaux P, Francioli P, Glauser MP, Moreillon P.

Infect Immun. 2001 Feb;69(2):657-64.

14.

Clonal associations among Staphylococcus aureus isolates from various sites of infection.

Booth MC, Pence LM, Mahasreshti P, Callegan MC, Gilmore MS.

Infect Immun. 2001 Jan;69(1):345-52. Erratum in: Infect Immun 2001 Mar;69(3):1976.

15.

Shear stress affects the kinetics of Staphylococcus aureus adhesion to collagen.

Li ZJ, Mohamed N, Ross JM.

Biotechnol Prog. 2000 Nov-Dec;16(6):1086-90.

PMID:
11101338
16.

Quantification of Staphylococcus aureus cell surface adhesins using flow cytometry.

Mohamed N, Visai L, Speziale P, Ross JM.

Microb Pathog. 2000 Dec;29(6):357-61.

PMID:
11095920
17.

Passive immunity in prevention and treatment of infectious diseases.

Keller MA, Stiehm ER.

Clin Microbiol Rev. 2000 Oct;13(4):602-14. Review.

18.

Antibodies for the prevention and treatment of viral diseases.

Sawyer LA.

Antiviral Res. 2000 Aug;47(2):57-77. Review.

PMID:
10996394
19.

Antiviral therapy to prevent and treat hepatitis B virus infection in hepatic allografts.

Perrillo RP.

Clin Transplant. 2000;14 Suppl 2:25-8. Review.

PMID:
10965961
20.

Supplemental Content

Support Center